REGULUS Trademark

Trademark Overview

On Friday, May 6, 2016, a trademark application was filed for REGULUS with the United States Patent and Trademark Office. The USPTO has given the REGULUS trademark a serial number of 87028238. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 17, 2020. This trademark is owned by Regulus Therapeutics Inc.. The REGULUS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Oligonucleotide preparations for therapeutic pharmaceutical purposes for a wide variety of conditions

Research and development of oligonucleotides
regulus

General Information

Serial Number87028238
Word MarkREGULUS
Filing DateFriday, May 6, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 16, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the mark "REGULUS" with varying sized circles forming the depiction of a larger circle starting at the top of the first "U" and increasing in size to the top of the letter "S" and starting from the bottom of the "S" and increasing in size to the bottom of the first "U".
Goods and ServicesOligonucleotide preparations for therapeutic pharmaceutical purposes for a wide variety of conditions
Goods and ServicesResearch and development of oligonucleotides

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 11, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegulus Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameRegulus Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, August 17, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 17, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 14, 2020EXTENSION 5 GRANTED
Friday, January 10, 2020EXTENSION 5 FILED
Tuesday, January 14, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 10, 2020TEAS EXTENSION RECEIVED
Friday, July 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2019EXTENSION 4 GRANTED
Wednesday, July 10, 2019EXTENSION 4 FILED
Wednesday, July 10, 2019TEAS EXTENSION RECEIVED
Thursday, January 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 8, 2019EXTENSION 3 GRANTED
Tuesday, January 8, 2019EXTENSION 3 FILED
Tuesday, January 8, 2019TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 6, 2018EXTENSION 2 GRANTED
Friday, July 6, 2018EXTENSION 2 FILED
Friday, July 6, 2018TEAS EXTENSION RECEIVED
Wednesday, January 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 8, 2018EXTENSION 1 GRANTED
Monday, January 8, 2018EXTENSION 1 FILED
Monday, January 8, 2018TEAS EXTENSION RECEIVED
Tuesday, July 11, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 10, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 13, 2017EXAMINER'S AMENDMENT ENTERED
Friday, March 10, 2017ASSIGNED TO LIE
Friday, March 10, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 10, 2017EXAMINERS AMENDMENT E-MAILED
Friday, March 10, 2017EXAMINERS AMENDMENT -WRITTEN
Saturday, February 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 24, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 24, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 26, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, August 26, 2016PRIORITY ACTION E-MAILED
Friday, August 26, 2016PRIORITY ACTION WRITTEN
Tuesday, August 23, 2016ASSIGNED TO EXAMINER
Thursday, May 12, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 10, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

regulus conditions research development oligonucleotides variety wide preparations therapeutic pharmaceutical purposes